Lilly (Eli) & Co. Business Finance Contracts & Agreements

59 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Eli Lilly and Company Officers’ Certificate Establishing Six Series of Notes under 1991 Indenture
Indenture Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2025
Eli Lilly and Company Underwriting Agreement with Barclays, BofA, Citigroup, Deutsche Bank, and Goldman Sachs (2025)
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2025
Eli Lilly and Company Officers’ Certificate Establishing Series of Notes under 1991 Indenture
Indenture Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2024
Eli Lilly and Company Underwriting Agreement with BNP Paribas, Citigroup, Goldman Sachs, J.P. Morgan, and Morgan Stanley (August 2024)
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2024
Eli Lilly and Company Amended and Restated 2002 Stock Plan (as amended May 6, 2024)
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2024
Description of Common Stock of Eli Lilly and Company
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2024
Eli Lilly and Company Officers’ Certificate Establishing Series of Notes under 1991 Indenture
Indenture Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2024
Eli Lilly and Company Underwriting Agreement with BofA Securities, Barclays, Citigroup, Deutsche Bank, and Mizuho (February 2024)
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2024
Eli Lilly and Company Officers’ Certificate Establishing Four Series of Notes under 1991 Indenture
Indenture Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2023
Eli Lilly and Company Underwriting Agreement with J.P. Morgan, Credit Suisse, Goldman Sachs, and Morgan Stanley (February 2023)
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2023
Eli Lilly and Company Shareholder Value Award Agreement (Non-Executive Officer) under 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Eli Lilly and Company 1.625% Notes Due 2043—Description of Debt Securities
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2022
Description of Eli Lilly and Company’s 0.500%, 1.125%, and 1.375% Euro-Denominated Notes Due 2033, 2051, and 2061
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2022
Eli Lilly and Company Officers’ Certificate Establishing Four Series of Notes under 1991 Indenture
Indenture Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2021
Eli Lilly and Company Underwriting Agreement with Merrill Lynch International, Barclays, BNP Paribas, Citigroup, and Deutsche Bank (September 2021)
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Release Agreement between Eli Lilly and Company and Joshua L. Smiley, Effective February 9, 2021
Release Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2021
Eli Lilly and Company Restricted Stock Unit Award Agreement for Executive Officer under 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Eli Lilly and Company Officers’ Certificate Establishing 2.500% Notes Due 2060 and Additional 2.250% Notes Due 2050 under Indenture
Indenture Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2020
Underwriting Agreement between Eli Lilly and Company and Underwriters for $1.1 Billion Notes Offering (2020)
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2020
Eli Lilly and Company Officers’ Certificate Establishing 2.250% Notes Due 2050 under Indenture with Deutsche Bank Trust Company Americas
Indenture Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2020
Underwriting Agreement between Eli Lilly and Company and BofA Securities, Barclays, Credit Suisse, and Goldman Sachs (April 24, 2020)
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2020
Restricted Stock Unit Award Agreement between Eli Lilly and Company and Michael Harrington under the 2002 Lilly Stock Plan
Equity Distribution Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2020
Description of Eli Lilly and Company’s 0.625% and 1.700% Euro Notes Due 2031 and 2049
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2020
Description of Eli Lilly and Company 7 1/8% Notes Due 2025
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2020
Description of Eli Lilly and Company 6.77% Notes Due 2036
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2020
Description of Eli Lilly and Company’s 1.000% Notes Due 2022, 1.625% Notes Due 2026, and 2.125% Notes Due 2030
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2020
Description of Eli Lilly and Company Common Stock and Related Shareholder Rights
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2020
Eli Lilly and Company Officers’ Certificate Establishing 0.625% and 1.700% Euro Notes under 1991 Indenture
Indenture Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2019
Underwriting Agreement between Eli Lilly and Company and Underwriters for €1.6 Billion Notes Offering (2019)
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2019
Amended and Restated 2002 Lilly Stock Plan (Effective May 7, 2018)
Equity Distribution Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2018
Eli Lilly and Company Officers’ Certificate Establishing Series of Notes under Indenture (May 2017)
Indenture Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2017
Eli Lilly and Company Underwriting Agreement with J.P. Morgan, Merrill Lynch, and Morgan Stanley (May 2017)
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2017
Eli Lilly and Company Officers’ Certificate Establishing Terms of 2015 Euro-Denominated Notes under Indenture
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2015
Underwriting Agreement between Eli Lilly and Company and Multiple Underwriters for €2.1 Billion Notes Offering (May 2015)
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2015
Eli Lilly and Company Officers’ Certificate Establishing Series of Notes under 1991 Indenture
Indenture Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2015
Underwriting Agreement between Eli Lilly and Company and Underwriters for $2.2 Billion Notes Offering
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2015
First Amendment to Stock and Asset Purchase Agreement between Novartis AG and Eli Lilly and Company
Purchase Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2015
Eli Lilly and Company Officers’ Certificate Establishing Terms of 1.950% and 4.650% Notes under 1991 Indenture
Indenture Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2014
Eli Lilly and Company Underwriting Agreement with Merrill Lynch, Barclays, and Citigroup (2014)
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2014
Eli Lilly and Company Restricted Stock Unit Award Agreement for Executive Officers (2010)
Equity Distribution Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2010